Nov 13, 2025 04:01PM
Oct 18, 2025 08:00AM
Aug 20, 2025 04:05PM
Jun 2, 2025 04:01PM
Mar 20, 2025 04:01PM
Nov 25, 2024 07:00AM
Feb 28, 2022 04:01PM NuCana to Participate in Two Upcoming Investor Conferences
Feb 28, 2022 04:01PM
Feb 22, 2022 04:01PM
Feb 22, 2022 04:01PM
Feb 22, 2022 04:01PM
Nov 18, 2021 04:01PM
Nov 18, 2021 04:01PM
Nov 10, 2021 08:00AM NuCana to Present at the Jefferies 2021 London Healthcare Conference
Nov 10, 2021 08:00AM
Nov 1, 2021 04:39PM
Nov 1, 2021 04:01PM
Nov 1, 2021 04:01PM
Sep 29, 2021 08:01AM
Sep 29, 2021 08:00AM
Sep 29, 2021 08:00AM NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer
Sep 16, 2021 08:00AM
Sep 16, 2021 08:00AM
Sep 15, 2021 08:00AM
Sep 15, 2021 08:00AM
Aug 19, 2021 04:01PM
Aug 19, 2021 04:01PM
Dec 21, 2020 04:11PM NuCana (NCNA) Adds Andrew Kay as Board Chair
Dec 21, 2020 04:01PM
Dec 1, 2020 09:25AM
Nov 30, 2020 05:41PM
Nov 30, 2020 04:04PM
Nov 30, 2020 04:01PM
Nov 30, 2020 04:01PM
Sep 17, 2020 09:29AM Pre-Open Movers 09/17: (SRNE) (MLHR) (RIGL) Higher; (SBBP) (NCNA) (SNOW) Lower (more...)
Mar 4, 2020 07:06AM
Mar 4, 2020 07:00AM
Mar 4, 2020 07:00AM
Jan 27, 2020 07:09AM
Jan 27, 2020 07:00AM
Jan 27, 2020 07:00AM
Nov 13, 2019 04:01PM NuCana Reports Third Quarter 2019 Financial Results and Provides Business Update
Nov 13, 2019 04:01PM
Oct 25, 2019 07:08AM
Oct 25, 2019 07:00AM
Oct 25, 2019 07:00AM
Aug 21, 2019 04:01PM
Aug 21, 2019 04:01PM
Jun 12, 2019 07:24PM NuCana Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Acelarin® for the Treatment of Biliary Tract Cancer
Jun 12, 2019 07:24PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All